IGFBP2 and idiopathic pulmonary fibrosis: Given that IGFBP2 serum levels decrease in response to initiation of anti-fibrotic medication in IPF patients, it is possible that serum IGFBP2 is upregulated in response to inflammation or damage within the lungs [36].